4.16.2020 TDOC Bearish Divergence up to the Monthly TF
COVID has pumped this stock to overbought.
Teladoc Health now anticipates revenues for the first quarter of 2020 to be in the range of $180-181 million, up 40% year over year. Adjusted EBITDA is expected in the band of $10-11 million compared with $1.2 million in the first quarter of 2019.
-NFA
Teladoc Health now anticipates revenues for the first quarter of 2020 to be in the range of $180-181 million, up 40% year over year. Adjusted EBITDA is expected in the band of $10-11 million compared with $1.2 million in the first quarter of 2019.
-NFA
註釋
4.17.2020 Short
My opinions only not trading advice.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。
My opinions only not trading advice.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。